Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03707808 |
| Title | Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab (myDAvIpNi) |
| Acronym | myDAvIpNi |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Universitair Ziekenhuis Brussel |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | BEL |